(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.17%) $82.49
(1.72%) $2.07
(-0.66%) $2 342.20
(-1.30%) $27.30
(-0.29%) $958.70
(0.18%) $0.934
(0.30%) $11.02
(0.12%) $0.797
(0.01%) $93.31
Live Chart Being Loaded With Signals
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes...
Stats | |
---|---|
Šios dienos apimtis | 35 959.00 |
Vidutinė apimtis | 10 800.00 |
Rinkos kapitalizacija | 3.32M |
EPS | $0 ( 2024-02-08 ) |
Kita pelno data | ( $-4.60 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.350 |
ATR14 | $0.0670 (1.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-23 | Jantzen Beth | Buy | 98 039 | Incentive Stock Option (right to buy) |
2023-03-23 | Jantzen Beth | Buy | 91 667 | Common Stock |
2023-03-23 | Jantzen Beth | Buy | 1 961 | Non-Qualified Stock Option (right to buy) |
2023-03-23 | Shorrock Clay | Buy | 98 039 | Incentive Stock Option (right to buy) |
2023-03-23 | Shorrock Clay | Buy | 91 667 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 100 transactions |
Buy: 2 995 668 | Sell: 475 226 |
Tūris Koreliacija
Applied DNA Sciences Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
HOFV | 0.972 |
SLGL | 0.956 |
OM | 0.952 |
ARQT | 0.952 |
APWC | 0.948 |
OMGA | 0.948 |
MCRB | 0.948 |
HA | 0.947 |
INMD | 0.947 |
SATL | 0.946 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
GXII | -0.949 |
EACPU | -0.947 |
MSAC | -0.945 |
KAII | -0.934 |
AEAC | -0.932 |
LGTO | -0.93 |
HERA | -0.929 |
AGGR | -0.929 |
PRLH | -0.928 |
LGAC | -0.926 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Applied DNA Sciences Inc Koreliacija - Valiuta/Žaliavos
Applied DNA Sciences Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $13.37M |
Bruto pelnas: | $5.53M (41.39 %) |
EPS: | $-0.760 |
FY | 2023 |
Pajamos: | $13.37M |
Bruto pelnas: | $5.53M (41.39 %) |
EPS: | $-0.760 |
FY | 2022 |
Pajamos: | $18.17M |
Bruto pelnas: | $5.05M (27.82 %) |
EPS: | $-0.930 |
FY | 2021 |
Pajamos: | $9.03M |
Bruto pelnas: | $4.93M (54.59 %) |
EPS: | $-2.07 |
Financial Reports:
No articles found.
Applied DNA Sciences Inc
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.